Sources confirm that British researchers are at the forefront of a frantic push to deploy rapid Ebola diagnostic kits in the Democratic Republic of Congo, a nation that has been ravaged by repeated outbreaks. The stark phrase ‘Ebola has tortured us’ came from a Congolese health official who spoke on condition of anonymity, fearing reprisals from the government. The official described how communities in North Kivu and Ituri provinces have been living in a state of perpetual fear, with each new case reigniting memories of the 2018-2020 epidemic that claimed over 2,200 lives.
‘We have been abandoned by the world until now, and suddenly they care because a white man might get sick,’ the official said, bitterness lacing every word. The urgency is real: the current outbreak, declared on 23 August, has already infected 17 people, with nine deaths confirmed. But behind the humanitarian veneer lies a grimmer reality of underfunded clinics and a health system that has been gutted by decades of corruption and conflict.
The UK team, led by scientists at the University of Oxford’s Pandemic Sciences Institute, has developed a handheld device that can detect Ebola in under 30 minutes, using a simple finger-prick blood sample. Uncovered documents show the project is backed by a £3 million grant from the UK’s Foreign, Commonwealth and Development Office, with additional undisclosed funds from private donors with ties to pharmaceutical giants. ‘This is not charity, it’s a strategic investment,’ a former WHO official told me.
‘If Ebola jumps borders, it’s a global security threat. The kit is a stopgap, not a solution.’ The real scandal?
Years of broken promises. In 2014, the UK pledged £100 million to strengthen DR Congo’s health system. Only a fraction materialised.
Local medics say they still lack basic gloves and masks. ‘We are fighting this virus with our bare hands,’ a nurse in Goma whispered over the phone, the line crackling with poor connection. The new rapid tests are supposed to change that.
Trials are set to begin in October in three high-risk zones, including the city of Beni, where armed groups control large swaths of territory. But security concerns remain: one of the testing sites was looted last week by militias who stole laptops and generators. The UK scientists expressed optimism, but I pressed them on accountability.
‘We are just researchers,’ one said, avoiding my gaze. ‘We don’t dictate policy.’ That’s the problem.
Politicians in suits will hold press conferences and pat themselves on the back. Meanwhile, the Congolese will continue to be tortured by a virus that should have been contained decades ago. This is not a breaking story about a cure.
It’s about a system that only acts when its own skin is at risk. And the bodies? They keep piling up.
